1. Home
  2. SMX vs NCEL Comparison

SMX vs NCEL Comparison

Compare SMX & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$16.30

Market Cap

19.7M

Sector

Technology

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.36

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMX
NCEL
Founded
N/A
2008
Country
Ireland
Switzerland
Employees
19
4
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
20.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SMX
NCEL
Price
$16.30
$3.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8M
31.5K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.83
52 Week High
$490.00
$5.12

Technical Indicators

Market Signals
Indicator
SMX
NCEL
Relative Strength Index (RSI) 68.63 52.22
Support Level $15.39 $3.03
Resistance Level $20.09 $3.54
Average True Range (ATR) 2.10 0.26
MACD 0.73 -0.01
Stochastic Oscillator 92.42 55.71

Price Performance

Historical Comparison
SMX
NCEL

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: